The Best CDB, Hemp, and THC Products
I counted over 175 talks and posters at the 33rd annual gathering of the International Cannabinoid Research Society (ICRS), which convened in Toronto at the end of June. In accordance with longstanding ICRS policy, all speakers presented new findings and data that had not yet been published in a peer-reviewed journal. But this year’s 4-day … Read more
A recent study conducted in the United Kingdom has failed to identify cannabis as a risk factor for psychosis. The study, which was published in the journal Psychological Medicine, is the first of its kind to look at the association between cannabis use and the risk of developing psychotic disorders. The study involved over 11,000 … Read more
The use of data analytics and data science has become increasingly important to the medical world in recent years. This is particularly true when it comes to understanding the possible effects of drugs, such as cannabis, on mental health. A recent study conducted in the United Kingdom has failed to identify cannabis as a risk … Read more
Cannabinoid receptors CB1 and CB2 are the definitive and best-known targets of endogenous and plant-derived cannabinoids, but they’re far from the only ones. Several phytocannabinoids, including cannabidiol (CBD), for example, and the two primary endocannabinoids — anandamide and 2-AG — have been shown to interact with peroxisome proliferator-activated receptors, or PPARs1 (pronounced pee-parrs), which are … Read more